PT KIMIA FARMA SUNGWUN PHARMACOPIA

Founded on January 25 2016 and is the first pharmaceutical raw materials factory in Indonesia. This is a collaboration with a joint venture scheme between PT Kimia Farma (Persero) Tbk and PT Sungwun Pharmacopia Indonesia as representatives of Sungwun Pharmacopia Co Ltd from South Korea. KFSP's aims and objectives are to work in the chemical industry, by building a sustainable drug raw material factory with the initial products Active Pharmaceutical Ingredients (API) or also called Medicinal Raw Materials (BBO) and High Function Chemical (HFC).

Domiciled in Lippo Cikarang, Bekasi, West Java, KFSP produces 19 (nineteen) items of active medicinal raw materials, namely Simvastatin, Atorvastatin, Rosuvastatin, Clopidogrel, Tenofovir, Lamivudine, Zidovudine, Efavirenz, Entecavir, Gefitinib, Remdesivir, Attapulgite, Bisoprolol, Candesartan, Azithromycin, Amlodipine, Povidone Iodine, Sitagliptine, and Risperidone. Apart from producing active medicinal raw materials, the Company will also produce 6 (six) HFC items, namely Lauroyl Lysine, Dextrin Palmitate (PAM Series), Dibutyl Lauroyl Glutamide, Dibutyl Ethylhexanoyl Glutamide, Cholesteryl Chloride, Cholesteryl Nonanoate which are used as raw materials for cosmetics and food. supplement.

The composition of shareholders is 80.67% PT Kimia Farma (Persero) Tbk and 19.33% Sungwun Pharmacopia Co Ltd.

Address: Jl Angsana Raya Blok A06 - 001 Delta Silicon Cikarang Industrial Estate - Bekasi

Phone : (021) 89916857